UAB Clinical Trials Advance IgA Nephropathy Treatment Options

Four pivotal clinical trials, co-led by UAB's Dana Rizk, M.D., have significantly improved the treatment landscape for IgA nephropathy patients. These developments offer new therapeutic options for individuals who previously had limited success, highlighting the critical impact of clinical research in delivering advanced medical care.